Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN111978237A details a novel Cu-catalyzed four-component coupling for high-purity maleimide intermediates, offering significant cost reduction and supply chain reliability.
Novel DES-mediated synthesis of benzoxazine derivatives offers green, high-yield routes for pharmaceutical intermediates, reducing costs and environmental impact.
Novel carbonylation method using sulfonyl chlorides avoids toxic thiols. High purity thioesters for pharma intermediates with simplified supply chain.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for quinazolinone derivatives. Discover cost-effective manufacturing and high-purity supply chain solutions.
Novel Mo/Cu co-catalyzed method for high-purity triazole intermediates. Reduces steps and costs for API manufacturing with mild conditions.
Patent CN115286578B reveals metal-free synthesis for trifluoromethyl pyrazoles. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102516162A reveals a green copper-catalyzed nitration method. Offers high purity, cost reduction in API manufacturing, and reliable supply chain solutions.
Discover a novel copper-catalyzed route for polysubstituted 4,5-dihydropyrazoles offering simplified operations and cost reduction in pharmaceutical intermediate manufacturing.
Novel metal-free synthesis of trifluoromethyl pyrazoles via CN115286578B. Offers cost reduction and scalable supply for pharmaceutical and agrochemical manufacturing.
Novel metal-free synthesis method offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates via patent CN115353482B.
Patent CN108689892B discloses a novel CuI-catalyzed route for 3-sulfonylated indanones, offering mild conditions and high yields for cost-effective pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed synthesis patent CN116640146B offers efficient route for pharma intermediates with simplified post-treatment and scalable production capabilities.
Patent CN114181168A reveals a Selectfluor-mediated C-H activation route for benzothiazinones, offering high purity and simplified manufacturing for pharmaceutical supply chains.
Novel Pd-catalyzed route using benzisoxazole offers high yields and broad functional group tolerance for scalable pharmaceutical intermediate production.
Patent CN115353511A details a safe, multi-component synthesis of trifluoromethyl-biheterocycles using palladium catalysis, offering significant cost reduction in pharmaceutical intermediate manufacturing.
A novel metal-free photocatalytic method for preparing deuterated intermediates using visible light, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN111423381A details a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and scalable production capabilities.
Patent CN103242223A details a green Pd-catalyzed oxidative decarboxylative coupling for 2-pyridyloxydiaryl ketones, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN109972165A details electrochemical synthesis of beta-trifluoromethyl amides, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Novel patent CN113979928B offers high-yield route for 2-chloro-5-nitropyridine. Reduces safety risks and improves supply chain stability for pharmaceutical intermediates.